[1] Patel R et al. Significance oft he positive XM test in kidney transplantation.N Engl J Med 1969; 280 814:735
[2] Tait BD et al. Consensus Guidelines on the Testing and Clinical Management Issues Associated With HLA and Non-HLA Antibodies in Transplantation. Transplantation 2013; 95(1):19–47
[3] Süsal C et al. Algorithms for the determination of unacceptable HLA antigen mismatches in kidney transplant recipients. Tissue Antigens 2013; 82(2):83–92
[4] Süsal C et al. Determination of unacceptable HLA antigen mismatches in kidney transplant recipients: recommendations of the German Society for Immunogenetics. Tissue Antigens 2015; 86(5):317–323
[5] Morales-Benrostroetal LE et al. Natural human leukocyte antigen antibodies found in non-alloimmunized health males. Transplantation 2008; 86:1111
[6] Schnaidt et al. HLA antibody specification using single-antigen beads – a technical solution for the prozone effect. Transplantation 2011; 87:813
[7] Amico P et al. Clinical relevance of pretransplant donor-specific HLA antibodies detected by single-antigen flow-beads. Transplantation 2009; 87:1681–8
[8] Loupy et al. Complement-Binding Anti-HLA Antibodies and Kidney-Allograft Survival. N Engl J Med 2013; 369(26):1215–1226
[9] Lachmann N et al. Anti-human leukocyte antigen and donor-specific antibodies detected by luminex posttransplant serve as biomarkers for chronic rejection of renal allografts.Transplantation 2009; (27):1505–13
[10] Cai J et al. Humoral theory of transplantation: some hot topics. Br Med Bull 2013; 105:139–55ihm